BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15611828)

  • 1. [Radioactive iodine therapy in Graves' hyperthyroidism].
    Andrade VA; Gross JL; Maia AL
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):159-65. PubMed ID: 15611828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease in children.
    Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
    Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D; Voth E; Schicha H
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
    Wartofsky L
    Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of radioiodine in adolescent Graves' disease.
    Teelucksingh S; Singh V; Balkaran B
    Ann Trop Paediatr; 2001 Dec; 21(4):335-8. PubMed ID: 11732151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperthyroidism: current concepts and management].
    Wemeau JL
    Rev Prat; 2005 Jan; 55(2):149-57. PubMed ID: 15825995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
    Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
    Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optimal treatment for pediatric Graves' disease is radioiodine.
    Rivkees SA; Dinauer C
    J Clin Endocrinol Metab; 2007 Mar; 92(3):797-800. PubMed ID: 17341574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
    Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
    Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.